drugset / Trial / NCT00654394

Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects

NCT00654394

Phase 3 Completed 200 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine the changes in the carotid artery when subjects receive high or low doses of rosuvastatin.

Timeline

Start
2000-01
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule